GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9 billion (£1.5 billion). As per the terms of the deal, shareholders of the publicly-listed Sierra Oncology will be paid $55 per share in cash. Sierra Oncology is engaged in developing targeted therapies for the treatment of rare […]
Swiss healthcare company Roche has launched the Elecsys Anti-p53 immunoassay to help in the diagnosis of various types of cancer by the in vitro quantitative determination of anti-p53 antibodies. The Anti-p53 immunoassay test will help physicians in diagnosing oesophageal cancer, breast cancer, and bowel cancer in patients, in combination with other diagnostic tests, said Roche. […]
Cancer has become a common term nowadays as most of the people are being diagnosed with different types of cancer. Cancer means abnormal and unregulated proliferation of cells from a specific organ with the ability to create their own blood supply and break away from the origin and spread to other parts of the body. […]